§ 12-504.1. Communication to prescriber of specific biological product dispensed
West's Annotated Code of MarylandHealth OccupationsEffective: October 1, 2017
Effective: October 1, 2017
MD Code, Health Occupations, § 12-504.1
§ 12-504.1. Communication to prescriber of specific biological product dispensed
(a) Except as provided in subsection (d) of this section, within 5 business days after dispensing a biological product to a patient, the dispensing pharmacist or the pharmacist's designee shall communicate the specific biological product dispensed, including the name and manufacturer of the biological product, to the prescriber.
(b) Except as provided in subsection (c) of this section:
(c) If the mechanisms listed in subsection (b)(1) of this section are not available, the communication required under subsection (a) of this section may be provided by facsimile, telephone, electronic transmission, or other means.
(d) The communication requirement under subsection (a) of this section does not apply if:
Credits
Added by Acts 2017, c. 726, § 2, eff. Oct. 1, 2017.
MD Code, Health Occupations, § 12-504.1, MD HEALTH OCCUP § 12-504.1
Current with all legislation from the 2023 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |